XTL Biopharmaceuticals Ltd ADR (XTLB) — Defensive Interval Ratio
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Defensive Interval Ratio of 144 days as of March 2025. Defensive assets of $871.00K (cash $-, short-term investments $772.00K, receivables $99.00K) cover 144 days of daily cash needs of $6.05K/day. See XTL Biopharmaceuticals Ltd ADR current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
XTL Biopharmaceuticals Ltd ADR Defensive Interval Ratio (2003–2024)
This chart shows how XTL Biopharmaceuticals Ltd ADR's Defensive Interval Ratio has evolved across 22 annual periods from 2003 to 2024. As of March 2025, the ratio stands at 144 days, meaning defensive assets of $871.00K can fund 144 days of operations without new revenue. See net asset quality index of XTL Biopharmaceuticals Ltd ADR to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for XTL Biopharmaceuticals Ltd ADR (2003–2024)
The table below presents the year-by-year Defensive Interval Ratio for XTL Biopharmaceuticals Ltd ADR from 2003 to 2024, covering 22 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see XTL Biopharmaceuticals Ltd ADR (XTLB) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 144 days | $871.00K | $6.05K/day | $- | $772.00K | ▼ -979 days |
| 2023 | 1123 days | $634.00K | $564.38/day | $- | $605.00K | ▼ -2191 days |
| 2022 | 3314 days | $1.70 Million | $512.33/day | $- | $1.63 Million | ▼ -1824 days |
| 2021 | 5138 days | $3.25 Million | $632.88/day | $- | $3.16 Million | ▲ +1674 days |
| 2020 | 3465 days | $2.41 Million | $695.89/day | $- | $2.41 Million | ▼ -111 days |
| 2019 | 3576 days | $2.27 Million | $635.62/day | $- | $2.27 Million | ▼ -3477 days |
| 2018 | 7053 days | $4.89 Million | $693.15/day | $- | $4.87 Million | ▲ +3626 days |
| 2017 | 3427 days | $2.82 Million | $821.92/day | $- | $2.81 Million | ▲ +2956 days |
| 2016 | 471 days | $426.00K | $904.11/day | $- | $414.00K | ▲ +231 days |
| 2015 | 240 days | $287.00K | $1.19K/day | $- | $251.00K | ▲ +235 days |
| 2014 | 5 days | $13.00K | $2.64K/day | $- | $- | ▼ -415 days |
| 2013 | 420 days | $1.40 Million | $3.34K/day | $- | $1.28 Million | ▲ +35 days |
| 2012 | 386 days | $1.74 Million | $4.52K/day | $- | $1.62 Million | ▼ -450 days |
| 2011 | 836 days | $1.44 Million | $1.72K/day | $- | $1.37 Million | ▲ +390 days |
| 2010 | 446 days | $1.18 Million | $2.64K/day | $- | $1.07 Million | ▲ +392 days |
| 2009 | 54 days | $105.00K | $1.94K/day | $- | $- | ▼ -18 days |
| 2008 | 72 days | $394.00K | $5.49K/day | $- | $40.00K | ▼ -673 days |
| 2007 | 745 days | $10.95 Million | $14.71K/day | $- | $10.60 Million | ▼ -1550 days |
| 2006 | 2295 days | $21.39 Million | $9.32K/day | $- | $20.95 Million | ▲ +2230 days |
| 2005 | 65 days | $431.00K | $6.59K/day | $- | $- | ▼ -1069 days |
| 2004 | 1135 days | $10.98 Million | $9.68K/day | $- | $10.14 Million | ▼ -1150 days |
| 2003 | 2285 days | $18.78 Million | $8.22K/day | $- | $18.08 Million | — |